Aligos Therapeutics Cash Flow Statement (2021-2025) | ALGS

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -27.67M-29.82M-33.12M-37.71M-35.62M-19.92M-18.62M-21.89M-22.95M-18.79M-18.04M-27.89M-34.86M5.06M-19.26M-82.15M43.09M-15.86M-31.54M
Depreciation and Depletion 0.74M0.80M0.80M0.72M0.70M0.60M0.50M0.51M0.50M0.40M0.30M0.40M0.30M0.30M0.30M0.23M0.20M0.30M0.20M
Share-based Compensation 2.76M3.45M3.59M3.65M3.79M3.99M3.49M3.42M3.66M3.20M3.21M2.58M2.65M2.06M2.04M1.71M0.96M1.16M1.47M
Gains from Sales and Divestitures 0.10M0.18M0.25M0.32M0.07M0.09M0.09M0.09M0.00M0.00M0.00M
Gains from Investment Securities 0.18M2.19M0.03M-0.03M0.02M1.07M14.37M62.13M-61.49M-1.68M4.21M
Asset Writedowns and Impairment 0.70M
Non-cash Items 0.75M1.09M24.53M16.76M2.19M0.20M3.20M3.73M4.46M4.86M5.47M6.05M3.08M3.44M0.15M0.17M0.25M0.31M0.40M
Cash from Operations -29.80M-23.02M-25.37M-37.48M-20.43M-25.04M-17.14M-16.78M-22.39M-13.62M-20.34M-22.66M-22.75M-19.49M-20.10M-18.40M-20.91M-15.50M-24.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.13M0.15M0.19M0.28M0.31M0.32M0.37M0.38M0.39M0.36M0.37M0.38M0.39M0.54M0.47M0.37M0.32M0.72M0.71M
Depreciation & Amortization (CF) 0.74M0.80M0.80M0.72M0.70M0.60M0.50M0.51M0.50M0.40M0.30M0.40M0.30M0.30M0.30M0.23M0.20M0.30M0.20M
Change in Working Capital
Change in Account Payables -0.50M-1.33M1.12M0.40M0.74M-0.99M0.17M1.81M-1.92M0.42M-0.30M-0.42M0.33M3.98M-4.08M-0.17M1.73M-0.40M0.75M
Change in Accured Expenses -4.24M6.10M4.00M3.88M-6.07M-6.35M0.90M2.39M-0.94M-1.26M-1.46M4.58M-4.80M0.02M2.10M1.29M-4.76M1.41M1.40M
Other Working Capital Changes -0.91M-1.54M-1.54M12.06M12.44M-3.69M-14.91M0.57M-2.32M-2.32M-2.01M-1.49M-0.64M-0.63M-0.70M-0.71M-0.50M-1.00M-0.80M
Investing Activities
Capital Expenditures 0.31M0.15M0.10M0.34M0.52M0.33M0.00M0.09M0.01M
Change in Acquisitions & Divestments 10.00M3.00M10.00M37.45M36.22M20.00M25.00M0.01M30.00M20.00M20.00M70.00M
Cash from Investing Activities 9.69M9.85M-0.04M-16.48M-60.40M-9.98M32.48M11.60M19.99M25.00M-0.01M-0.01M-88.64M39.99M10.40M19.97M-44.07M-39.42M47.68M
Financing Activities
Cash from Financing Activities 0.08M0.10M77.95M0.55M-0.02M0.08M-0.02M0.12M-0.00M0.41M-0.02M87.94M-0.02M0.28M-0.00M0.10M101.74M-0.18M-0.05M
Additional items
Change in Cash -20.02M-13.07M52.54M-53.41M-80.86M-34.93M15.33M-5.06M-2.40M11.80M-20.37M65.27M-111.41M20.78M-9.71M1.67M36.77M-55.10M23.29M
Free Cash Flow -30.10M-23.17M-25.46M-37.82M-20.95M-25.37M-17.14M-16.87M-22.39M-13.62M-20.34M-22.66M-22.75M-19.49M-20.10M-18.40M-20.91M-15.50M-24.34M
Net Cash Flow -20.02M-13.07M52.54M-53.41M-80.86M-34.93M15.33M-5.06M-2.40M11.80M-20.37M65.27M-111.41M20.78M-9.71M1.67M36.77M-55.10M23.29M